Articles

Dr Bobby Qureshi, the first surgeon in the UK to carry out implant surgery using light adjustable lenses, he talks to OTEurope about the procedure

Diabetic retinopathy is a rising threat as the diabetic population increases

Progress in glaucoma followed a slow, steady course in 2009, according to specialists

Retinal tissue response after PASCAL laser photocoagulation

The Endoscopic CycloPhotocoagulation (ECP) technique provides an option for surgical glaucoma management, addressing ciliary aqueous production without the deeply destructive effects of classic ablative procedures. Dr Liegner explains

Ensure that your human capital knows how to win loyal patients and can help your practice grow

2009 heralded more interesting developments for ophthalmology. OTEurope asked some of Europe's leading key opinion leaders for their thoughts on the news and developments that generated most excitement or had most significance in the Cataract & Refractive sector

Professor David Wong reports on the third Heavy Tamponade meeting in Amsterdam and explains the background from the first and second events

Alcon acquires Optinol and enters glaucoma surgical market.

Ophthalmic surgeon Bobby Qureshi is the first in the UK to implant light-adjustable lenses (LALs), which have the capacity to be altered after surgery to provide the best vision for each individual eye without glasses.

Northeastern University engineering professor Jeffrey Ruberti and his research colleagues are breaking new ground in the technique known as "hybrid tissue engineering" by attempting to combine cow tissue with human tissue to produce corneas for human transplant.

Rayner Intraocular Lens Limited, has marked a milestone with a celebration to honour the 60th anniversary of the implantation of the first intraocular lens (IOL) in a patient. The late Sir Harold Ridley implanted the first IOL on 29 November 1949 at St. Thomas Hospital in London. Due to the controversial nature of the surgery, this first surgery was conducted in almost total secrecy.

Fight for Sight has announced £500,000 funding for a new research programme to develop an optimal model of care services for patients with inherited retinal diseases. The five-year programme will be led by Professor Graeme Black, Director of the National Institute for Health Research Manchester Biomedical Research Centre, supported by Professor Tony Moore of Moorfields Eye Hospital and Miss Susie Downes of Oxford Eye Hospital.

Findings published in the European Journal of Ophthalmology have found that intravitreal bevacizumab (IVB) combined with panretinal photocoagulation in patients with open angle neovascular glaucoma (NVG) can reduce iris and angle neovascularization and temporarily inhibit further PAS formation.

In the December issue of the American Journal of Ophthalmology Brandeis University researchers published a paper about the highly precise scleral lens, to treat severe cornea or ocular surface disease, the Boston Ocular Surface Prosthesis (BOS-P).

The Scottish Medicines Consortium (SMC) has announced that Saflutan (tafluprost) has been accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure (IOP) in open angle glaucoma and ocular hypertension

Performing surgery in unfamiliar surroundings.

Transconjunctival Muscle Suturing is a new technique that decreases the size of opening by approximately one third.

New model produces results comparable with current glaucoma assessment methods

A proprietary tonometer has been found to be compatible with the Goldmann tonometer in several clinical trials.

Diabetic macular oedema responds to treatment with ranibizumab according to the results of the RESOLVE study.

A doctor's perspective on what influences IOL lens design.

Several manufacturers are developing femtosecond laser technology as a tool for multiple applications in cataract surgery. Three surgeons, who presented at this year's ESCRS Congress look at its uses and results.

Data suggest endothelial stability with Descemet's stripping automated endothelial keratoplasty but is longer-term follow-up needed?

A superior refractive corneal correction can be achieved by the preservation of corneal tissue as well as optimization of ablation profiles that are better adapted to human sight.

A new Tecnis intraocular lens harnesses the ease of implantation of a one-piece implant design and combines it with a glistening-free hydrophobic acrylic material for another next generation IOL.

A comparison study of patients who underwent minimally invasive strabismus surgery (MISS) with a total dissection of the plicated part of the rectus muscle and those who had MISS where only a marginal dissection was performed.

Advanced Cell Technology has filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic-stem-cell-derived retinal cells to treat patients with Stargardt?s Macular Dystrophy (SMD).

The ExciStar XS series from Coherent, Inc. represents a compact, economical excimer laser offering performance and lifetime characteristics.

A study into the process of retinal cell death could hold the key to stopping a variety of eye diseases that cause blindness, according to a report from a team of researchers from the Yale School of Medicine reported in the journal Investigative Ophthalmology & Visual Science.